Loading…

Improved production of 2-keto-3-deoxy-d-glycero-galactononulosonic acid (KDN) using FastPrep-CLEAs

•Staphylococcus carnosus N-acetylneuraminate aldolase (ScNAL) was a good catalyst for d-mannose.•ScNAL thermal stability was improved by cross-linked immobilization to form FastPrep-CLEAs.•A 2:1 pyruvate:d-mannose ratio and 37°C provided the highest KDN conversion to date (90%).•ScNAL FastPrep-CLEAs...

Full description

Saved in:
Bibliographic Details
Published in:Process biochemistry (1991) 2014-01, Vol.49 (1), p.90-94
Main Authors: García García, María Inmaculada, Sola Carvajal, Agustín, García Carmona, Francisco, Sánchez Ferrer, Álvaro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Staphylococcus carnosus N-acetylneuraminate aldolase (ScNAL) was a good catalyst for d-mannose.•ScNAL thermal stability was improved by cross-linked immobilization to form FastPrep-CLEAs.•A 2:1 pyruvate:d-mannose ratio and 37°C provided the highest KDN conversion to date (90%).•ScNAL FastPrep-CLEAs showed good operational stability. FastPrep cross-linked enzyme aggregates of N-acetylneuraminate aldolase from Staphylococcus carnosus (ScNAL-FpCLEAs) were prepared in order to improve the synthesis of 2-keto-3-deoxy-d-glycero-galactononulosonic acid (KDN), an important building block for therapeutic glycolipids and a possible marker for human prostate cancer. ScNAL-FpCLEAs showed improved thermostability compared with the free enzyme, doubling its half-life at 60°C. When the effect of substrate ratio (pyruvate:d-mannose) and temperature on the yield of KDN was studied at its optimum pH (pH 7.0), 90% conversion in only 8h was reached in the presence of 0.6M d-mannose and 1.2M pyruvate at 37°C. This is the highest conversion described to date for enzymatic KDN synthesis. In addition, ScNAL-FpCLEAs exhibited enhanced catalytic activity and stability and could be recycled 10 times with no loss of activity. These results suggest the biotechnological potential of using FastPrepCLEAs to obtain valuable biocatalysts.
ISSN:1359-5113
1873-3298
DOI:10.1016/j.procbio.2013.10.014